VTR(300381)2025-01-17 16:00Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 30 million and 40 million yuan for the year 2024, compared to a loss of 10.7497 million yuan in the same period last year[2]. - The net profit after deducting non-recurring gains and losses is expected to be between 0 and 10 million yuan, compared to a loss of 19.7204 million yuan in the previous year[2]. Factors Contributing to Performance Improvement - The increase in performance is attributed to enhanced R&D investment and improved product performance, along with significant reductions in production and procurement costs[4]. - The company has achieved success in expanding its overseas market, leading to increased revenue from high-margin products[4]. Non-Recurring Gains - Non-recurring gains are expected to contribute approximately 30 million yuan to the net profit, primarily from government subsidies, investment income, and gains from the acquisition of German Victory Enzymes GmbH[5].